Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Exploratory Study on the Safety and Efficacy of BEN301 Injection in the Treatment of Autoimmune Diseases

NCT07527936 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT07527936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07527936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Exploratory Study on the Safety and Efficacy of BEN301 Injection in the Treatment of Autoimmune Diseases
Lead sponsor
RenJi Hospital
Phase
Phase 1
Overall status
Suspended
Start date
April 20, 2026
Completion date
February 28, 2029
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic inflammatory myopathies(iim), rheumatoid arthritis (ra), sjogren's syndrome (ss), systemic sclerosis (ssc)